Search - tctmd.com

Displaying 21 - 40 of 62

Sort: Relevancy | Date

Presentation TCT 2022

COSIRA-II – Trial Design and Status Update

Presenter: Gregg Stone

September 18, 2022

Presentation TCT 2022

Reducer Data and a “No Option Patient”

Presenter: Natalia Pinilla

September 18, 2022

Presentation TCT 2022

Reducer Device Overview and Mechanism of Action

Presenter: Allen Jeremias

September 18, 2022

Presentation TCT 2022

Angina - the Scope of the Problem

Presenter: Timothy Henry

September 18, 2022

Presentation TCT 2022

TCT 199: A Symptom-Stratified Analysis of the Objective Randomised Blinded Investigation With Optimal Medical Therapy of Angioplasty in Stable Angina Trial

Presenter: Rachel Pathimagaraj

September 18, 2022

Presentation TCT 2022

TCT 198: Differential Improvement in Angina and Health-related Quality of Life after Percutaneous Coronary Interventions in Focal and Diffuse Coronary Artery Disease

Presenter: Takuya Mizukami

September 18, 2022

Presentation TCT 2022

TCT 284: Long-Term Cost-Effectiveness of Fractional Flow Reserve in Stable and Unstable Angina Patients

Presenter: David Hong

September 17, 2022

Presentation TCT 2022

TCT 255: Clinical and Coronary Physiology Characteristics of Patients With Residual Angina After Percutaneous Coronary Intervention

Presenter: Damien Collison

September 17, 2022

News Daily News

COURAGE and ORBITA Had No Impact on Elective PCI Rates in UK

Michael O'Riordan

September 15, 2022

News Conference News ESC 2022

CV Care Around Noncardiac Surgery: New ESC Guidelines

Michael O'Riordan

September 07, 2022

News Conference News ESC 2022

Routine Functional Testing Unnecessary After Stenting: POST-PCI

Yael L. Maxwell

September 06, 2022

News Conference News ESC 2022

Earlier Evolocumab Cut CVD, CV Mortality Over Longer Term: FOURIER-OLE

Michael O'Riordan

August 31, 2022

News Conference News ESC 2022

CMR, PET Similar for Identifying Coronary Disease After CTA: Dan-NICAD 2

Todd Neale

August 29, 2022

News Conference News ESC 2022

ALL-HEART: Gout Drug Allopurinol No Help in CV Prevention

Shelley Wood

August 27, 2022

News Daily News

Even With Revascularization in ISCHEMIA, Skipping Meds Hurt Health Status

Todd Neale

August 19, 2022

News Daily News

After COVID-19, Unvaccinated at Risk for Long-term CVD Complications

Michael O'Riordan

August 16, 2022

News Daily News

LVEF Analysis Digs Anew Into Revascularization Benefits in Ischemic CAD

Michael O'Riordan

July 11, 2022

News Daily News

hs-Troponins and the Chest Pain Guidelines: Experts Call for Clarification

Yael L. Maxwell

July 08, 2022

News

‘Less Is More’ for Patients With AF and Stable CAD: AFIRE Analysis

Todd Neale

June 17, 2022

News Daily News

Short-term Testosterone Use Doesn’t Spur CV Events: Meta-analysis

Caitlin E. Cox

June 10, 2022

Advertisement

COSIRA-II – Trial Design and Status Update

Reducer Data and a “No Option Patient”

Reducer Device Overview and Mechanism of Action

Angina - the Scope of the Problem

TCT 199: A Symptom-Stratified Analysis of the Objective Randomised Blinded Investigation With Optimal Medical Therapy of Angioplasty in Stable Angina Trial

TCT 198: Differential Improvement in Angina and Health-related Quality of Life after Percutaneous Coronary Interventions in Focal and Diffuse Coronary Artery Disease

TCT 284: Long-Term Cost-Effectiveness of Fractional Flow Reserve in Stable and Unstable Angina Patients

TCT 255: Clinical and Coronary Physiology Characteristics of Patients With Residual Angina After Percutaneous Coronary Intervention

COURAGE and ORBITA Had No Impact on Elective PCI Rates in UK

CV Care Around Noncardiac Surgery: New ESC Guidelines

Routine Functional Testing Unnecessary After Stenting: POST-PCI

Earlier Evolocumab Cut CVD, CV Mortality Over Longer Term: FOURIER-OLE

CMR, PET Similar for Identifying Coronary Disease After CTA: Dan-NICAD 2

ALL-HEART: Gout Drug Allopurinol No Help in CV Prevention

Even With Revascularization in ISCHEMIA, Skipping Meds Hurt Health Status

After COVID-19, Unvaccinated at Risk for Long-term CVD Complications

LVEF Analysis Digs Anew Into Revascularization Benefits in Ischemic CAD

hs-Troponins and the Chest Pain Guidelines: Experts Call for Clarification

‘Less Is More’ for Patients With AF and Stable CAD: AFIRE Analysis

Short-term Testosterone Use Doesn’t Spur CV Events: Meta-analysis

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content